Not investment advice. NasdaqScan is a free, independent educational tool. Results are automated and may contain errors. Trading involves risk of loss. Read full disclaimer
DAILY CHART

REGN daily chart – Regeneron Pharmaceuticals Inc sideways range & retest on the daily timeframe

NASDAQ

You are looking at the daily chart. Each candle is one trading day, and every date on this page is a single trading day. NasdaqScan has no weekly-chart signal for this stock.

On the daily chart, REGN has been moving sideways between $637.80 and $847.00 since 23 Jul 2026.

The pattern: price breaks out below a sideways range, the pullback back into the range fails, and price comes back to retest the low. Traders also call this a spring. On this page NasdaqScan flags the daily candle (the trading day) that makes the retest.

DAILYDaily chart: each candle is one trading day.

Daily chart. The purple band is the sideways range of the latest signal; green triangles mark the trading days NasdaqScan detected a retest.

Sideways ranges on the daily chart

RangeStartedEndedHow it endedRetest signals (trading day)
23 Jul 2026Open——
9 Jan 20262 Jun 2026 (144 days)Broke below the range at $591.52—
21 May 202526 Nov 2025 (189 days)Broke above the range at $790.98—
8 Jan 20255 Jun 2025 (148 days)Broke below the range at $476.49—
18 Aug 202328 Feb 2024 (194 days)Broke above the range at $998.33—
9 Mar 202310 Jul 2023 (123 days)Broke below the range at $688.5230 Jun 2023 (BO accepted)
25 May 20225 Apr 2023 (315 days)Broke above the range at $837.55—
5 Nov 20218 Apr 2022 (154 days)Broke above the range at $747.42—

Retest signals on the daily chart

  • 30 Jun 2023 (daily candle): retest of the low after a breakout below a sideways range, 113 days after the range began (BO accepted)

Other stocks with a recent daily-chart retest

All daily-chart retest signals →
All NASDAQ stocks with weekly retest patterns →

Past patterns don't predict future price moves. This page shows what an automated algorithm detected and is not financial advice. Read the disclaimer.